Adenosine and Adenosine Receptors: Advances in Atrial Fibrillation.
Baptiste MailleNathalie LaleveeMarion MarlingeJuliette VahdatGiovanna MottolaClara DegioanniLucille De MariaVictor KleinYuichi TamuraFrédéric FranceschiJean-Claude DeharoRégis GuieuJulien FromonotPublished in: Biomedicines (2022)
Atrial fibrillation (AF) is the most common arrhythmia in the world. Because the key to developing innovative therapies that limit the onset and the progression of AF is to fully understand the underlying molecular mechanisms of AF, the aim of the present narrative review is to report the most recent advances in the potential role of the adenosinergic system in the pathophysiology of AF. After a comprehensive approach describing adenosinergic system signaling and the mechanisms of the initiation and maintenance of AF, we address the interactions of the adenosinergic system's signaling with AF. Indeed, adenosine release can activate four G-coupled membrane receptors, named A 1 , A 2A , A 2B and A 3 . Activation of the A 2A receptors can promote the occurrence of delayed depolarization, while activation of the A 1 receptors can shorten the action potential's duration and induce the resting membrane's potential hyperpolarization, which promote pulmonary vein firing, stabilize the AF rotors and allow for functional reentry. Moreover, the A 2B receptors have been associated with atrial fibrosis homeostasis. Finally, the adenosinergic system can modulate the autonomous nervous system and is associated with AF risk factors. A question remains regarding adenosine release and the adenosine receptors' activation and whether this would be a cause or consequence of AF.